Status:
UNKNOWN
Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
2019 Novel Coronavirus Infection
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
The investigators plan to carry out an experimental study on the preventive effect of recombinant human interferon alpha nasal drops on the infection of 2019 new coronavirus in medical staff.
Detailed Description
The investigators plan to carry out an experimental study enrolling more than 2000 medical staff and divide participants into low-risk group and high-risk group according to whether they can directly ...
Eligibility Criteria
Inclusion
- Formally serving medical staff in Taihe Hospital;
Exclusion
- pregnant women;
- severe chronic diseases who are unable to participate in daily routine work;
- fever (temperature≥37.3 ° ) and / or respiratory symptoms.
Key Trial Info
Start Date :
January 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2020
Estimated Enrollment :
2944 Patients enrolled
Trial Details
Trial ID
NCT04320238
Start Date
January 21 2020
End Date
June 1 2020
Last Update
March 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taihe Hospital
Shiyan, Hubei, China